Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characteristics and outcomes of ibrutinib-associated musculoskeletal toxicities in CLL patients
    Meeting Abstract

    Rhodes, J.; Mato, A.; Hubbard, R.; Chong, E.; Winchell, N.; Kennard, K.; Nasta, S.; Landsburg, D.; Gerson, J.; Barta, S.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Hypertension in ibrutinib-treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Roeker, L.; Yazdy, M.; Gashonia, L.; Narkhede, M.; Goodfriend, J.; Rhodes, J.; Kennard, K.; Dorsey, C.; Sarmasti, L.; Calivo, K.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Predicting tumor lysis syndrome in venetoclax-treated CLL patients
    Meeting Abstract

    Roeker, L.; Brander, D.; Coombs, C.; Schuster, S.; Allan, J.; Hill, B.; Lansigan, E.; Cheson, B. D.; Yazdy, M.; Lamanna, N.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Factors impacting treatment selection in treatment-naive patients with CLL: A multicenter study
    Meeting Abstract

    Rhodes, J.; Sail, K.; Yazdy, M.; Hill, B.; Shadman, M.; Tuncer, H. H.; Winter, A.; Kennard, K.; Allan, J.; Ujjani, C.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Treatment and prognostic testing patterns in patients with chronic lymphocytic leukemia: Updates from the informCLL (TM) real-world registry
    Meeting Abstract

    Ghosh, N.; Mato, A.; Barrientos, J.; Brander, D.; Pagel, J.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Upasani, S.; Sundaram, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Treatment sequencing and outcomes in patients with chronic lymphocytic leukemia: The informCLL (TM) real-world registry
    Meeting Abstract

    Mato, A.; Ghosh, N.; Barrientos, J.; Brander, D.; Pagel, J.; Gutierrez, M.; Kadish, K.; Tomlinson, B.; Ipe, D.; Sundaram, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Phase I/II triple therapy study of umbralisib and ublituximab ("U2") combined with checkpoint inhibition in patients with rel/ref CLL and Richter's transformation
    Meeting Abstract

    Mato, A.; Svoboda, J.; Luning-Prak, E.; Schuster, S.; Tsao, P.; Dorsey, C.; Sarmasti, L.; Becker, P.; Brander, D.; Geyer, M.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Myeloid neoplasm with eosinophilia/basophilia and ETV6-ABL1 rearrangements: Cell of origin and response to tyrosine kinase inhibition
    Meeting Abstract

    Yao, J.; Xu, L.; Aypar, U.; Londono, D.; Gao, Q.; Baik, J.; Dietz, J.; Benayed, R.; Sigler, A.; Yabe, M.; more...
    Journal of Molecular Diagnostics (2020)

    Fulltext@MSK | Save
  • Outcomes of allogeneic stem cell transplantation for patients with t(6:9) AML - A strong case for allogeneic stem cell transplantation in first complete remission
    Editorial

    Stahl, M.; Tallman, M. S.
    British Journal of Haematology (2020)

    Fulltext@MSK | Save
  • Drug modulation by nuclear condensates: Concentration of antineoplastic agents into spatial compartments influences activity
    Editorial

    Viny, A. D.; Levine, R. L.
    Science (2020)

    Fulltext@MSK | Save